(Q36037071)

English

Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues (English)
Barbro Eriksson
Christos Toumpanakis
Michael A Morse
Paola Tomassetti
Matthias M Weber
David R Fogelman
Janice L Pasieka
Abakar Mahamat
John Newell-Price

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit